Download presentation
Presentation is loading. Please wait.
Published byEvan Alexander Modified over 6 years ago
1
The Correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) Classification With Prognosis and EGFR Mutation in Lung Adenocarcinoma Naoki Yanagawa, MD, PhD, Satoshi Shiono, MD, PhD, Masami Abiko, MD, PhD, Shin-ya Ogata, MD, PhD, Toru Sato, MD, PhD, Gen Tamura, MD, PhD The Annals of Thoracic Surgery Volume 98, Issue 2, Pages (August 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 The relationship between the frequency of the wild-type (red bars) and mutated (blue bars) EGFR and the histopathologic subtypes of adenocarcinoma according to the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society classification. (AIS = adenocarcinoma in situ; IMA = invasive adenocarcinoma; MIA = minimally invasive adenocarcinoma; MP = micropapillary.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 (A) The overall survival curve according to International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) lung adenocarcinoma classifications of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA, solid line); lepidic (large dash-dot-dash line); papillary (dash-space-dash line); acinar (dotted line); invasive adenocarcinoma (IMA, shall dash-dot-dash); solid (dashed line); and micropapillary (dash-2 dots-dash line). (B) The overall survival curve according to three modified tumor grade groups (low, solid line; intermediate, large dashed line; and high, small dashed line) after IASLC/ATS/ERS lung adenocarcinoma classification. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.